180 related articles for article (PubMed ID: 35836081)
1. Bioluminescence-Optogenetics: A Practical Guide.
Stern MA; Skelton H; Fernandez AM; Gutekunst CN; Berglund K; Gross RE
Methods Mol Biol; 2022; 2525():333-346. PubMed ID: 35836081
[TBL] [Abstract][Full Text] [Related]
2. Applications of Bioluminescence-Optogenetics in Rodent Models.
Stern MA; Skelton H; Fernandez AM; Gutekunst CN; Gross RE; Berglund K
Methods Mol Biol; 2022; 2525():347-363. PubMed ID: 35836082
[TBL] [Abstract][Full Text] [Related]
3. Improved Locomotor Recovery in a Rat Model of Spinal Cord Injury by BioLuminescent-OptoGenetic (BL-OG) Stimulation with an Enhanced Luminopsin.
Ikefuama EC; Kendziorski GE; Anderson K; Shafau L; Prakash M; Hochgeschwender U; Petersen ED
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361784
[TBL] [Abstract][Full Text] [Related]
4. Bioluminescence-Optogenetics.
Berglund K; Stern MA; Gross RE
Adv Exp Med Biol; 2021; 1293():281-293. PubMed ID: 33398820
[TBL] [Abstract][Full Text] [Related]
5. Luminopsins integrate opto- and chemogenetics by using physical and biological light sources for opsin activation.
Berglund K; Clissold K; Li HE; Wen L; Park SY; Gleixner J; Klein ME; Lu D; Barter JW; Rossi MA; Augustine GJ; Yin HH; Hochgeschwender U
Proc Natl Acad Sci U S A; 2016 Jan; 113(3):E358-67. PubMed ID: 26733686
[TBL] [Abstract][Full Text] [Related]
6. The BioLuminescent-OptoGenetic in vivo response to coelenterazine is proportional, sensitive, and specific in neocortex.
Gomez-Ramirez M; More AI; Friedman NG; Hochgeschwender U; Moore CI
J Neurosci Res; 2020 Mar; 98(3):471-480. PubMed ID: 31544973
[TBL] [Abstract][Full Text] [Related]
7. Step-function luminopsins for bimodal prolonged neuromodulation.
Berglund K; Fernandez AM; Gutekunst CN; Hochgeschwender U; Gross RE
J Neurosci Res; 2020 Mar; 98(3):422-436. PubMed ID: 30957296
[TBL] [Abstract][Full Text] [Related]
8. Defining parameters of specificity for bioluminescent optogenetic activation of neurons using in vitro multi electrode arrays (MEA).
Prakash M; Medendorp WE; Hochgeschwender U
J Neurosci Res; 2020 Mar; 98(3):437-447. PubMed ID: 30152529
[TBL] [Abstract][Full Text] [Related]
9. Bioluminescent Optogenetics 2.0: Harnessing Bioluminescence to Activate Photosensory Proteins In Vitro and In Vivo.
Crespo EL; Bjorefeldt A; Prakash M; Hochgeschwender U
J Vis Exp; 2021 Aug; (174):. PubMed ID: 34424228
[TBL] [Abstract][Full Text] [Related]
10. Combined Optogenetic and Chemogenetic Control of Neurons.
Berglund K; Tung JK; Higashikubo B; Gross RE; Moore CI; Hochgeschwender U
Methods Mol Biol; 2016; 1408():207-25. PubMed ID: 26965125
[TBL] [Abstract][Full Text] [Related]
11. Improved trafficking and expression of luminopsins for more efficient optical and pharmacological control of neuronal activity.
Zhang JY; Tung JK; Wang Z; Yu SP; Gross RE; Wei L; Berglund K
J Neurosci Res; 2020 Mar; 98(3):481-490. PubMed ID: 31670406
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory luminopsins: genetically-encoded bioluminescent opsins for versatile, scalable, and hardware-independent optogenetic inhibition.
Tung JK; Gutekunst CA; Gross RE
Sci Rep; 2015 Sep; 5():14366. PubMed ID: 26399324
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive activation of optogenetic actuators.
Birkner E; Berglund K; Klein ME; Augustine GJ; Hochgeschwender U
Proc SPIE Int Soc Opt Eng; 2014 Feb; 8928():. PubMed ID: 27965518
[TBL] [Abstract][Full Text] [Related]
14. Novel luciferase-opsin combinations for improved luminopsins.
Park SY; Song SH; Palmateer B; Pal A; Petersen ED; Shall GP; Welchko RM; Ibata K; Miyawaki A; Augustine GJ; Hochgeschwender U
J Neurosci Res; 2020 Mar; 98(3):410-421. PubMed ID: 28862809
[TBL] [Abstract][Full Text] [Related]
15. Enhancing Motor and Sensory Axon Regeneration after Peripheral Nerve Injury Using Bioluminescent Optogenetics.
Ecanow A; Berglund K; Carrasco D; Isaacson R; English AW
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555724
[TBL] [Abstract][Full Text] [Related]
16. Engineering luminopsins with improved coupling efficiencies.
Slaviero AN; Gorantla N; Simkins J; Crespo EL; Ikefuama EC; Tree MO; Prakash M; Björefeldt A; Barnett LM; Lambert GG; Lipscombe D; Moore CI; Shaner NC; Hochgeschwender U
Neurophotonics; 2024 Apr; 11(2):024208. PubMed ID: 38559366
[TBL] [Abstract][Full Text] [Related]
17. Engineering luminopsins with improved coupling efficiencies.
Slaviero A; Gorantla N; Simkins J; Crespo EL; Ikefuama EC; Tree MO; Prakash M; Björefeldt A; Barnett LM; Lambert GG; Lipscombe D; Moore CI; Shaner NC; Hochgeschwender U
bioRxiv; 2023 Nov; ():. PubMed ID: 38045286
[TBL] [Abstract][Full Text] [Related]
18. Bioluminescent optogenetic (BL-OG) activation of neurons during mouse postnatal brain development.
Crespo EL; Prakash M; Bjorefeldt A; Medendorp WE; Shaner NC; Lipscombe D; Moore CI; Hochgeschwender U
STAR Protoc; 2021 Sep; 2(3):100667. PubMed ID: 34286295
[TBL] [Abstract][Full Text] [Related]
19. BL-OG: BioLuminescent-OptoGenetics.
Moore CI; Berglund K
J Neurosci Res; 2020 Mar; 98(3):469-470. PubMed ID: 31840283
[No Abstract] [Full Text] [Related]
20. Efficient opto- and chemogenetic control in a single molecule driven by FRET-modified bioluminescence.
Björefeldt A; Murphy J; Crespo EL; Lambert GG; Prakash M; Ikefuama EC; Friedman N; Brown TM; Lipscombe D; Moore CI; Hochgeschwender U; Shaner NC
Neurophotonics; 2024 Apr; 11(2):021005. PubMed ID: 38450294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
